The National Rosacea Society have announced their latest round of rosacea grants. 5 new grants have been awarded, some as followup to previous grants.
- Dr. Cremers will investigate the levels of angiogenesis markers, such as vascular endothelial growth factor (VEGF), in the conjunctiva and eyelids of patients with severe ocular rosacea, compared with normal subjects.
- Dr. Richard Gallo, and Dr. Kenshi Yamasaki will continue their NRS-funded research of how cathelicidins, one of the body’s own natural antibiotics, may play a role in the development of rosacea symptoms.
- Dr. Richard Granstein will continue research on the role of adenosine triphosphate (ATP), an agent produced by nerves that earlier NRS-funded studies had shown initiates an inflammatory response in human dermal endothelial cells.
- Dr. Kent T. Keyser, will study the effects of nicotine on rosacea, to investigate which intracellular signaling pathways are affected and which cellular mechanisms may cause a reaction in rosacea.
- Dr. Martin Steinhoff will study the role of neuroimmune interactions in the pathophysiology of rosacea.
Previous National Rosacea Society News:
- ATP Role in rosacea being studied
- NRS keen to expand rosacea research role
- NRS Blog: cathelicidins show allergic basis for rosacea ?
- NRS awards 5 more Rosacea Grants
- NRS ocular rosacea study published
- NRS Introduces Clinical Scorecard For Evaluating Rosacea Patients
- acne and rosacea common together (NRS)
- NRS updates rosacea patients web site
